Pacala Mark L
- SEC CIK
- 0001321250
In the past year, 1 open-market sale filing worth $200.0K and no purchases.
Current role at each company
- DFPH Starling Oncology, Inc.Directoras of Jul 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $200.0K
- 1 filing
- Net
- −$200.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Pacala Mark L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 (view filing) | Nov 18 | 2 days | Pacala Mark LDirector | SSale | −50.0K | $4.00 | −$200.0K | −22.2%175.0K after | 3 lots |
| Mar 28, 2025 (view filing)5:41 PM ET | Mar 26 | 2 days | Pacala Mark LDirector | PPurchase | +90.6K | $1.04 | +$94.3K | +67.4%225.0K after | |
| Mar 28, 2025 (view filing)5:41 PM ET | Mar 26 | 2 days | Pacala Mark LDirector | PPurchase | +42.3K | $0.125 | +$5.29K | –42.3K after | Derivative |